KTKiminobu Tanizawa

Kiminobu Tanizawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kiminobu Tanizawa has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Akihiko Yoshizawa

    Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan

    2 shared publications
  • Issei Oi

    Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

    2 shared publications
  • Kohei Fujita

    National Hospital Organization Kyoto Medical Center

    2 shared publications
  • Osamu Kanai

    Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

    2 shared publications
  • Shogo Toyama

    Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto-City, Kyoto, Japan

    2 shared publications
  • Takanori Ito

    Division of Respiratory Medicine, Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

    2 shared publications

Latest Publications

  • Longitudinal Quantitative Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis

    by Kiminobu Tanizawa, Tomohiro Handa, Michihiro Uyama, Tsuyoshi Oguma, Kohei Ikezoe, Naoya Tanabe, Ryoji Uozumi, Yoshinari Nakatsuka, Atsushi Matsunashi, Ryo Sakamoto, et al.

    Background: AIQCT is an artificial intelligence -based quantitative computed tomography (CT) image analysis software and was previously applied for cross-sectional evaluation of patients with idiopathic pulmonary fibrosis (IPF) Aims and Objectives: To investigate the clinical relevance of longitudinal quantitative changes in CT images of IPF. Methods: A retrospective observational study at a single interstitial lung disease (ILD) center. In 78 patients with IPF, CT images at baseline and 12 months later were quantitatively evaluated by AIQCT. The associations of 12-month changes in AIQCT indices (presented as the percentage of the whole lungs) with baseline clinical and AIQCT parameters, 12-month changes in pulmonary function tests and overall survival were analyzed. Results: Median absolute 12-month changes in normal area, fibrosis (reticulation and honeycombing) and ILD (fibrosis and ground-glass opacity) measured by the AIQCT were -3.0% [interquartile ranges, -0.8, 5.9], 0.9% [0.2, 2.1], and 0.8% [-0.2, 3.0]. Absolute 12-month changes in fibrosis and ILD were associated with fibrosis and ILD at baseline. An absolute 12-month change in fibrosis was associated with the percentage of predicted forced vital capacity (%DLCO) at baseline. Absolute 12-month changes in fibrosis and ILD correlated with 12-month changes in the percentage of predicted forced vital capacity (%FVC) (|r|=0.50-0.62) and %DLCO (|r|=0.24-0.34). An absolute 12-month increase in fibrosis predicted the mortality, independent of 12-month decline in %FVC and antifibrotic therapy (adjusted hazard ratio = 1.22) and fibrosis at baseline (adjusted hazard ratio = 1.17). Conclusions: The AIQCT may be useful to define the disease behavior of IPF in addition to physiological measurements.

  • Open Access

    Bronchoscopic removal of lower airway foreign body: a two-center retrospective cohort study

    by Shogo Toyama, Kenichiro Kudo, Kohei Fujita, Yuki Takigawa, Hiromi Watanabe, Issei Oi, Osamu Kanai, Ken Sato, Keiichi Fujiwara, Kiminobu Tanizawa, et al.

    Background: Tracheobronchial foreign body (FB) aspiration is a life-threatening condition, particularly in older adults. Despite its clinical significance, research on the etiology of adult FB aspiration, as well as real-world outcomes and complications associated with FB removal in lower airways, remains limited. Patients and methods: This was a two-center retrospective cohort study in Japan. We included adult patients aged 18 years or older who underwent bronchoscopic FB removal between April 2010 and March 2025. Results: A total of 28 patients were included in this analysis (mean age, 75.4 years [median age: 75 years]; range, 55–102 years). Nineteen patients (67.9%) were male. The most frequently reported symptoms were coughing (46.4%), sputum production (39.3%), and dyspnea (17.9%). A total of 30 FBs were identified, with dental prostheses (60.0%) being the most common type, followed by natural teeth (10.0%). FBs were slightly more common on the right side (53.3%) than on the left side (43.3%), with the right lower lobe being the most frequent site of lodgement (30.0%), followed by the left lower lobe (20.7%). The most frequently bronchoscopic findings were mucosal edema (36.7%) and bleeding (26.7%). FB removal was performed using flexible bronchoscopy in 26 patients (92.9), with the exception of two cases (7.1%) in which rigid bronchoscopy was employed. Bronchoscopy was performed in the endoscopy room for 21 patients (75.0%). Among the 28 patients, standard forceps were used in 24 (85.7%), followed by basket forceps, which was employed in 10 patients (35.7%). FB removal was successful in 26 (92.9%) patients. Regarding adverse events, hypoxia was the only complication observed, occurring in 18 patients (64.3%); no other adverse events were reported. Conclusions: Most FB in the lower airways can be successfully and safely removed via flexible bronchoscopy.

  • Open Access

    Single-centre retrospective experience of complications and outcomes of computed tomography-guided lung biopsy and interventions for the management of intrathoracic infections

    by Kohei Fujita, Naoki Fujimoto, Saiki Yoshimura, Shogo Toyama, Takanori Ito, Takuma Imakita, Issei Oi, Osamu Kanai, Yuki Yamamoto, Kiminobu Tanizawa

    Objective: To investigate the complications and outcomes of computed tomography (CT)-guided lung biopsy and interventions in the management of intrathoracic infections. Results: Twenty-nine patients were examined. Eleven (37.9%) patients were diagnosed with pulmonary nodules, and 18 (62.1%) underwent drainage of lung abscesses. The median age of the patients was 77 years, and 44.8% had a poor performance status. The major underlying diseases were hypertension and malignancies. The puncture site was mostly the right lower lobe (44.8%), whereas there were no cases of puncture in the left upper lobe. The nodule diagnostic success rate was 54.5% and the success rate of lung abscess drainage was 88.9%. The common organisms identified were Aspergillus , S. pneumoniae and S. aureus in the nodules and S. intermedius in the lung abscess drainage. Pigtail catheters were most commonly used for drainage (50%). Pneumothorax and hypoxaemia were the most common adverse events (13.8%), followed by fever (10.3%). Clinical trial registration : This retrospective study was registered in the UMIN Clinical Trials Registry (registration No. UMIN000055755). This clinical trial was registered on 6 October 2024 and is publicly available.


  • Open Access

    A case of clopidogrel-induced organizing pneumonia evaluated by lung biopsy and confirmed by accidental re-administration

    by Shogo Toyama, Kiminobu Tanizawa, Masatsugu Ouchi, Saiki Yoshimura, Naoki Fujimoto, Takanori Ito, Takuma Imakita, Issei Oi, Osamu Kanai, Kohei Fujita, et al.